• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于短信和互联网的自我报告系统增强疫苗安全性监测:来自美国大型综合医疗保健系统的见解:前瞻性队列研究。

A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study.

机构信息

Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.

Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, United States.

出版信息

JMIR Mhealth Uhealth. 2024 Oct 11;12:e58991. doi: 10.2196/58991.

DOI:10.2196/58991
PMID:39393058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512128/
Abstract

BACKGROUND

SMS text messaging- and internet-based self-reporting systems can supplement existing vaccine safety surveillance systems, but real-world participation patterns have not been assessed at scale.

OBJECTIVE

This study aimed to describe the participation rates of a new SMS text messaging- and internet-based self-reporting system called the Kaiser Permanente Side Effect Monitor (KPSEM) within a large integrated health care system.

METHODS

We conducted a prospective cohort study of Kaiser Permanente Southern California (KPSC) patients receiving a COVID-19 vaccination from April 23, 2021, to July 31, 2023. Patients received invitations through flyers, SMS text messages, emails, or patient health care portals. After consenting, patients received regular surveys to assess adverse events up to 5 weeks after each dose. Linkage with medical records provided demographic and clinical data. In this study, we describe KPSEM participation rates, defined as providing consent and completing at least 1 survey within 35 days of COVID-19 vaccination.

RESULTS

Approximately, 8% (164,636/2,091,975) of all vaccinated patients provided consent and completed at least 1 survey within 35 days. The lowest participation rates were observed for parents of children aged 12-17 years (1349/152,928, 0.9% participation rate), and the highest participation was observed among older adults aged 61-70 years (39,844/329,487, 12.1%). Persons of non-Hispanic White race were more likely to participate compared with other races and ethnicities (13.1% vs 3.9%-7.5%, respectively; P<.001). In addition, patients residing in areas with a higher neighborhood deprivation index were less likely to participate (5.1%, 16,503/323,122 vs 10.8%, 38,084/352,939 in the highest vs lowest deprivation quintiles, respectively; P<.001). Invitations through the individual's Kaiser Permanente health care portal account and by SMS text message were associated with the highest participation rate (19.2%, 70,248/366,377 and 10.5%, 96,169/914,793, respectively), followed by email (19,464/396,912, 4.9%) and then QR codes on flyers (25,882/2,091,975, 1.2%). SMS text messaging-based surveys demonstrated the highest sustained daily response rates compared with internet-based surveys.

CONCLUSIONS

This real-world prospective study demonstrated that a novel digital vaccine safety self-reporting system implemented through an integrated health care system can achieve high participation rates. Linkage with participants' electronic health records is another unique benefit of this surveillance system. We also identified lower participation among selected vulnerable populations, which may have implications when interpreting data collected from similar digital systems.

摘要

背景

短信文本消息和基于互联网的自我报告系统可以补充现有的疫苗安全监测系统,但尚未在大规模范围内评估实际参与模式。

目的

本研究旨在描述 Kaiser Permanente 副作用监测器 (KPSEM) 这一新的短信文本消息和基于互联网的自我报告系统在大型综合医疗保健系统内的参与率。

方法

我们对 Kaiser Permanente 南加州 (KPSC) 的患者进行了一项前瞻性队列研究,这些患者于 2021 年 4 月 23 日至 2023 年 7 月 31 日接种了 COVID-19 疫苗。患者通过传单、短信、电子邮件或患者健康护理门户收到邀请。同意后,患者定期接受调查,以评估每次剂量后长达 5 周的不良事件。与医疗记录的链接提供了人口统计学和临床数据。在本研究中,我们描述了 KPSEM 的参与率,定义为在 COVID-19 疫苗接种后 35 天内提供同意并完成至少 1 次调查。最低的参与率见于 12-17 岁儿童的父母(1349/152928,0.9%的参与率),最高的参与率见于 61-70 岁的老年人(39/329487,12.1%)。与其他种族和族裔相比,非西班牙裔白人更有可能参与(分别为 13.1%和 3.9%-7.5%;P<.001)。此外,居住在邻里贫困指数较高地区的患者参与度较低(分别为 5.1%,16503/323122 和 10.8%,38084/352939,在最高和最低贫困五分位数中;P<.001)。通过个人 Kaiser Permanente 医疗保健门户账户和短信发送邀请与最高参与率相关(分别为 19.2%,70248/366377 和 10.5%,96169/914793),其次是电子邮件(19464/396912,4.9%),然后是传单上的 QR 码(25882/2091975,1.2%)。基于短信的调查与基于互联网的调查相比,具有最高的持续每日响应率。

结论

本真实世界前瞻性研究表明,通过集成医疗保健系统实施的新型数字疫苗安全自我报告系统可以实现高参与率。与参与者的电子健康记录的链接是该监测系统的另一个独特优势。我们还发现某些弱势群体的参与率较低,这可能会对从类似数字系统收集的数据进行解释产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/810bede72ded/mhealth_v12i1e58991_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/58b57f11d1d1/mhealth_v12i1e58991_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/653fa85cf619/mhealth_v12i1e58991_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/810bede72ded/mhealth_v12i1e58991_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/58b57f11d1d1/mhealth_v12i1e58991_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/653fa85cf619/mhealth_v12i1e58991_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/11512128/810bede72ded/mhealth_v12i1e58991_fig3.jpg

相似文献

1
A Texting- and Internet-Based Self-Reporting System for Enhanced Vaccine Safety Surveillance With Insights From a Large Integrated Health Care System in the United States: Prospective Cohort Study.基于短信和互联网的自我报告系统增强疫苗安全性监测:来自美国大型综合医疗保健系统的见解:前瞻性队列研究。
JMIR Mhealth Uhealth. 2024 Oct 11;12:e58991. doi: 10.2196/58991.
2
Using Text Messaging Surveys in General Practice Research to Engage With People From Low-Income Groups: Multi-Methods Study.在一般实践研究中使用短信调查与低收入群体进行互动:多方法研究。
JMIR Mhealth Uhealth. 2024 Sep 5;12:e55354. doi: 10.2196/55354.
3
COVID-19 Vaccine Effectiveness and Digital Pandemic Surveillance in Germany (eCOV Study): Web Application-Based Prospective Observational Cohort Study.德国 COVID-19 疫苗有效性和数字大流行监测(eCOV 研究):基于网络应用的前瞻性观察队列研究。
J Med Internet Res. 2024 Jun 4;26:e47070. doi: 10.2196/47070.
4
Impact of Social Determinants of Health and Demographics on Refill Requests by Medicare Patients Using a Conversational Artificial Intelligence Text Messaging Solution: Cross-Sectional Study.利用对话式人工智能短信解决方案评估健康社会决定因素和人口统计学对医疗保险患者续药请求的影响:横断面研究。
JMIR Mhealth Uhealth. 2019 Nov 18;7(11):e15771. doi: 10.2196/15771.
5
Comparing the Efficacy of an Identical, Tailored Smoking Cessation Intervention Delivered by Mobile Text Messaging Versus Email: Randomized Controlled Trial.比较通过手机短信和电子邮件提供的相同定制戒烟干预措施的效果:随机对照试验。
JMIR Mhealth Uhealth. 2019 Sep 27;7(9):e12137. doi: 10.2196/12137.
6
Use of a text message-based pharmacovigilance tool in Cambodia: pilot study.柬埔寨基于短信的药物警戒工具的使用:试点研究。
J Med Internet Res. 2013 Apr 16;15(4):e68. doi: 10.2196/jmir.2477.
7
Text Messaging for Exercise Promotion in Older Adults From an Upper-Middle-Income Country: Randomized Controlled Trial.来自一个中高收入国家的针对老年人运动促进的短信干预:随机对照试验
J Med Internet Res. 2016 Jan 7;18(1):e5. doi: 10.2196/jmir.5235.
8
Text Messaging to Enhance Behavioral Health Treatment Engagement Among Justice-Involved Youth: Qualitative and User Testing Study.短信干预提升涉法青少年行为健康治疗参与度:定性与用户测试研究
JMIR Mhealth Uhealth. 2019 Apr 5;7(4):e10904. doi: 10.2196/10904.
9
Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation.短信与语音电话访谈用于免疫接种后不良事件主动监测的比较。
Vaccine. 2015 Jul 17;33(31):3689-94. doi: 10.1016/j.vaccine.2015.06.022. Epub 2015 Jun 12.
10
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.

本文引用的文献

1
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.通过时空回归和事后分层提高英国全国 COVID-19 感染调查的代表性。
Nat Commun. 2024 Jun 24;15(1):5340. doi: 10.1038/s41467-024-49201-4.
2
Digital Phenotyping: Data-Driven Psychiatry to Redefine Mental Health.数字表型:以数据为驱动的精神病学重新定义精神健康。
J Med Internet Res. 2023 Oct 4;25:e44502. doi: 10.2196/44502.
3
Uptake and adoption of the NHS App in England: an observational study.英格兰国民保健署应用程序的使用和采用:一项观察性研究。
Br J Gen Pract. 2023 Nov 30;73(737):e932-e940. doi: 10.3399/BJGP.2022.0150. Print 2023 Dec.
4
Digital health equity for older populations.老年人群的数字健康公平性。
Lancet Digit Health. 2023 Jul;5(7):e395. doi: 10.1016/S2589-7500(23)00114-0.
5
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.Ad.26.COV2.S 疫苗上市后安全性监测:2021 年 2 月至 2022 年 2 月向疫苗不良事件报告系统和 v-safe 报告的情况。
Vaccine. 2023 Jul 5;41(30):4422-4430. doi: 10.1016/j.vaccine.2023.06.023. Epub 2023 Jun 14.
6
Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes.加利福尼亚州在 COVID-19 政策变化后,按年龄、种族、族裔和社会经济地位划分的总体和远程医疗成瘾治疗利用率。
JAMA Health Forum. 2023 May 5;4(5):e231018. doi: 10.1001/jamahealthforum.2023.1018.
7
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial.比较移动应用程序和基于网络的通知平台在流感疫苗接种后不良事件监测中的使用:随机对照试验。
JMIR Public Health Surveill. 2023 May 8;9:e39700. doi: 10.2196/39700.
8
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.使用电子患者报告结局系统进行疫苗安全远程监测,加强德国和西班牙 GSK 四价季节性流感疫苗(2021/2022 季)的安全性监测。
Influenza Other Respir Viruses. 2023 Mar;17(3):e13098. doi: 10.1111/irv.13098.
9
The use of technology in vaccine safety communication: A systematic review of randomised controlled trials.技术在疫苗安全传播中的应用:随机对照试验的系统评价。
Patient Educ Couns. 2023 Jul;112:107707. doi: 10.1016/j.pec.2023.107707. Epub 2023 Mar 17.
10
Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort.在美国一个大型多元化队列中,按种族、民族、性别和医疗体系设置划分的 COVID-19 检测和不良结局的差异。
PLoS One. 2022 Nov 23;17(11):e0276742. doi: 10.1371/journal.pone.0276742. eCollection 2022.